NASDAQ: CELU - Celularity Inc.

Yield per half year: -27.86%
Sector: Healthcare

Celularity Inc.

Underestimation

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
10/10
0 48.73 -100% 5.7 -100%
P/S 1.44 33.76 -95.74%
P/BV 0.7995 4.83 -83.43%
P/FCF 0 61 -100%
Ev/Ebitda -0.3658 -22.19 -98.35%
Ev/S 3.15 22.57 -86.04%
Ev/FCF -1.68 68.74 -102.44%
E/P 0 0.0178 -100%

Efficiency

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
0/10
-785.17 4.98 -15876.16% -197.37 +297.82%
ROE -479.24 9.61 -5086.02%
ROA -136.42 0.3443 -39727.42%
ROIC 0 7.63 -100%
ROS -862.04 -25.17 3324.86%
ROCE -7.55 15.45 -148.88%

Debt

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
10/10
-0.4649 -3.68 -87.35% 0.2131 -318.21%
Nеt Debt/Ebitda -0.2765 -3.44 -91.96%
Debt/Ratio 0.4559 0.1986 129.58%
Debt/Equity 0 1.56 -100%
Debt/Net Income -0.3342 10.32 -103.24%

Dividends

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
0/10
0 0.5411 -100% 0 0%
Number of years of dividend growth 0 0.7368 -100%
DSI 0 0.2256 -100%
Average dividend growth 0 1.07 -100%
Average percentage for 5 years 0 0.498 -100%
Average percentage for payments 275.28 43.56 531.9%
Difference from average difference in sector -0.5411

Growth impulse

Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue in 5 years
1/10
7.92 -57.64 -113.74%
Growth impulse Ebitda in 5 years 636.94 -90.94 -800.4%
Growth impulse Net Income in 5 years -7951.8 -97.8 8030.67%
Growth impulse FCF in 5 years 3784.82 -49.48 -7749.19%
Growth impulse EPS in 5 years -3331.16 -32.41 10178.19%
IP Score
4.64/10

Similar companies

Alexion

Amgen

ABIOMED

Gilead Sciences

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription